Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Advance Syntex IPO and Kwality Pharmaceuticals IPO.
Advance Syntex IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Kwality Pharmaceuticals IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Advance Syntex IPO | Kwality Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Hem Securities Limited | Guiness Corporate Advisors Pvt Ltd |
| Registrar | Sharex Dynamic (India) Pvt Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Advance Syntex IPO is up to ₹2.52 Cr whereas the issue size of the Kwality Pharmaceuticals IPO is up to ₹6.21 Cr. The final issue price of Advance Syntex IPO is ₹12.00 per share and of Kwality Pharmaceuticals IPO is ₹45.00 per share.
| Advance Syntex IPO | Kwality Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹12.00 per share | ₹45.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 10000 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 21,00,000 shares | 13,80,000 shares |
| Issue Size Total (Amount) | up to ₹2.52 Cr | up to ₹6.21 Cr |
Advance Syntex IPO opens on Jun 30, 2016, while Kwality Pharmaceuticals IPO opens on Jun 30, 2016. The closing date of Advance Syntex IPO and Kwality Pharmaceuticals IPO is Jul 04, 2016, and Jul 08, 2016, respectively.
| Advance Syntex IPO | Kwality Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 30, 2016 | Jun 30, 2016 |
| Issue Close | Jul 04, 2016 | Jul 08, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Advance Syntex IPO P/E ratio is , as compared to Kwality Pharmaceuticals IPO P/E ratio of .
| Advance Syntex IPO | Kwality Pharmaceuticals IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Advance Syntex IPO retail investors (RII) are offered while in Kwality Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Advance Syntex IPO and in Kwality Pharmaceuticals IPO.
| Advance Syntex IPO | Kwality Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Advance Syntex IPO subscribed in total, whereas Kwality Pharmaceuticals IPO subscribed .
| Advance Syntex IPO | Kwality Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
